Join
Live feed
·
NEWSReleasevia Quantisnow
YS Biopharma Co. Ltd. logo

YS Biopharma shares are trading lower. The company announced interim results from the ongoing Phase 3 clinical trial of its PIKA Rabies Vaccine.

ByQuantisnow·Wall Street's wire, on your screen.
YS· YS Biopharma Co. Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track YS (YS Biopharma Co. Ltd.) and more on Quantisnow.